Article

Arkansas Online on 2023-10-24 08:58

Roche to buy maker of bowel disease drug

Roche Holding AG will pay $7.1 billion to acquire Telavant Holdings Inc., a developer of a promising therapy for treating inflammatory bowel disease, ...

Related news

Roche to buy maker of bowel disease drug nwaonline.com
Japan , Switzerland
Roche to buy bowel drugmaker Telavant for $7.1 billion - Mon, 23 Oct 2023 PST syndication.washingtonpost.com
Japan , Switzerland
Strong Swiss franc dents earnings at drug maker Roche Merced Sun-Star
Switzerland
Roche drug maker probed in Romanian graft case TimesDaily.com
Switzerland , Romania
Roche drug maker probed in Romania in graft case wkrg.com
Paris , Bucharest , Switzerland , Romania
Roche drug maker confirms it's being probed in Romania TimesDaily.com
Switzerland , Romania
TRoivant surges as Vivek Ramaswamy-found firm sells bowel disease drug for $7.1 billion thestreet.com
Japan , United States , Switzerland , Basel
Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery timesofisrael.com
Switzerland , France , Israel
Japanese drug maker Takeda agrees to buy Ireland's Shire The Fresno Bee
New York , Dublin , Ireland , Japan
Japanese drug maker Takeda agrees to buy Ireland’s Shire seattletimes.com
Dublin , Ireland , Japan
Japanese drug maker Takeda to buy Ireland's Shire apnews.com
New York , Asia , Massachusetts , Dublin , Tokyo Prefecture
Drug Company Lonza to Buy Capsule Maker From KKR wsj.com
Switzerland
Fritz Gerber, Former CEO of Swiss Drug Maker Roche, Dies at 91 wsj.com
Canton of Zurich , Switzerland
Inflammatory bowel disease drug ‘link...expressandstar.com